Company Filing History:
Years Active: 2023-2024
Title: The Innovative Contributions of Matthew Toczko
Introduction
Matthew Toczko is a notable inventor based in Raleigh, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that act as GABAA positive allosteric modulators. With a total of 3 patents to his name, Toczko's work is paving the way for advancements in treatments for various medical conditions.
Latest Patents
Among his latest patents, Toczko has developed crystalline salts or co-crystals of 2',6-difluoro-5′-[3-(1-hydroxy-1-methylethyl)-imidazo[1,2-b][1,2,4]triazin-7-yl]biphenyl-2-carbonitrile with p-toluenesulfonic acid. This innovation is described as a polymorphic salt or co-crystal of TPA023B, which has potential applications as a GABAA positive allosteric modulator. Additionally, he has disclosed GABAA positive allosteric modulators for the treatment of pruritic conditions and dermatitis, along with formulations that incorporate these compounds.
Career Highlights
Matthew Toczko is currently associated with Neurocycle Therapeutics, Inc., where he continues to push the boundaries of pharmaceutical research. His work focuses on creating effective treatments that can improve the quality of life for patients suffering from various conditions.
Collaborations
Toczko collaborates with Jed Hubbs, contributing to the innovative environment at Neurocycle Therapeutics, Inc. Their combined expertise enhances the development of new therapeutic solutions.
Conclusion
Matthew Toczko's contributions to the field of pharmaceuticals through his patents and collaborations are noteworthy. His innovative work continues to impact the medical community positively.